Literature DB >> 15325320

Benzene and hematopoietic malignancies.

David Pyatt1.   

Abstract

In certain countries outside of the United States, benzene remains a significant occupational hazard. This article provides a brief historical perspective of benzene use and general aspects of benzene toxicology, focusing primarily on benzene-induced hematotoxicity and leukemogenesis. Although the causal relationship between benzene and acute myelogenous leukemia is unequivocal, there has been considerable debate regarding the potential role of benzene exposure in the development of other hematopoietic malignancies, including chronic myelogenous leukemia, chronic lymphocytic leukemia, non-Hodgkin's lymphoma, and multiple myeloma. The relationship between benzene and these other diseases also is discussed briefly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325320     DOI: 10.1016/j.coem.2004.03.014

Source DB:  PubMed          Journal:  Clin Occup Environ Med        ISSN: 1526-0046


  4 in total

Review 1.  Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment.

Authors:  Cliona M McHale; Luoping Zhang; Martyn T Smith
Journal:  Carcinogenesis       Date:  2011-12-12       Impact factor: 4.944

2.  Steinmaus and Smith Respond to "Proximity to Gasoline Stations and Childhood Leukemia".

Authors:  Craig Steinmaus; Martyn T Smith
Journal:  Am J Epidemiol       Date:  2016-12-06       Impact factor: 4.897

3.  Parental, In Utero, and Early-Life Exposure to Benzene and the Risk of Childhood Leukemia: A Meta-Analysis.

Authors:  Frolayne M Carlos-Wallace; Luoping Zhang; Martyn T Smith; Gabriella Rader; Craig Steinmaus
Journal:  Am J Epidemiol       Date:  2015-11-20       Impact factor: 4.897

4.  The crosstalk between autophagy and apoptosis was mediated by phosphorylation of Bcl-2 and beclin1 in benzene-induced hematotoxicity.

Authors:  Yujiao Chen; Wei Zhang; Xiaoli Guo; Jing Ren; Ai Gao
Journal:  Cell Death Dis       Date:  2019-10-10       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.